Prostate cancer screening with prostate-specific antigen in hemodialysis patients

Urologia Internationalis

Volumn 78, Issue 4, 2007, Pages 334-337

  Horinaga, Minoru ^a,e   Kitamura, Koji ^b   Saito, Shiro ^c   Ukimura, Osamu ^d   Nakanoma, Takashi ^a   Okihara, Koji ^d   Kitagawa, Motonobu ^a   Nakanishi, Hiroyuki ^d   Miki, Tsuneharu ^d  

^a National Health Insurance Minamitama Hospital   (Japan)

^b Saiseikai Kyoto Hospital   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hemodialysis; Mass screening; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 34248213640     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100838     Document Type: Article

References (20)

1. Dhingra H, Laski ME: Outcomes research in dialysis. Semin Nephrol 2003;23:295-305.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
3. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-1161.
4. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993;270:860-864.
5. Dalkin BL, Ahmann FR, Kopp JB: Prostate-specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J Urol 1993;150:1837-1839.
6. Lindner A, Farewell VT, Sherrard DJ: High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis. Nephron 1981;27:292-296.
7. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM: Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 1989;14:119-123.
8. Makita Y, Iwamoto T, Sagiyama K, Nagaoka A, Kinjo M, Noguchi M, Aramaki K, Okuda S, Fujishima M: Two cases of urogenital malignancies in male patients undergoing maintenance haemodialysis. Int Urol Nephrol 1994;26:713-718.
9. Marple JT, MacDougall M: Development of malignancy in the end-stage renal disease patient. Semin Nephrol 1993;13:306-314.
10. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, et al.: Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999;354:93-99.
11. Sasagawa I, Nakada T, Hashimoto T, Ishigooka M, Kubota Y, Hirano K, Hirano J, Suzuki Y: Serum prostatic acid phosphatase, γ-seminoprotein and prostatic-specific antigen in hemodialysis patients. Urol Int 1992;48:181-183.
12. Kabalin JN, Hornberger JC: Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialysis. Urology 1991;37:308-310.
13. Monath JR, Burkart JM, Freedman BI, Pittaway DE, Russell GB, Assimos DG: Effects of hemodialysis on prostate-specific antigen. Urology 1993;42:398-400.
14. Djavan B, Shariat S, Ghawidel K, Guven-Marberger K, Remzi M, Kovarik J, Hoerl WH, Marberger M: Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: Is prostate cancer detection compromised in patients receiving long-term dialysis? Urology 1999;53:1169-1174.
15. Wolff JM, Ting O, Borchers H, Rohde D, Jakse G: Serum levels of prostate-specific antigen in men on hemodialysis. Anticancer Res 2000;20:5191-5193.
16. Tzanakis I, Kazoulis S, Girousis N, Kagia S, Spandidakis V, Karefillakis N, Georgila M, Cristoulakis I, Hatzilias P, Kallivretakis N: Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels. Nephron 2002;90:230-233.
17. Sasagawa I, Kubota Y, Hayami S, Adachi M, Nakada T, Miura H, Imai K: Serum levels of total and free prostate-specific antigen in men on hemodialysis. J Urol 1998;160:83-85.
18. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Piironen T, Abrahamsson PA, Stenman UH, Dowell B, Lovgren T, Lilja H: Free, complexed and total serum prostate-specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995;154:1090-1095.
19. Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J: Diagnostic significance of prostate-specific antigen and the development of a mass screening system for prostate cancer. J Urol 1995;154:1085-1089.
20. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, Jacobsen SJ, Lieber MM: Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995;75:347-353.